Acute myocardial infarction

Disease-a-Month

Volumn 59, Issue 3, 2013, Pages 83-96

  Boateng, Stephen ^a   Sanborn, Timothy ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ATROPINE; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CAPTOPRIL; CLOPIDOGREL; CREATINE KINASE; CREATINE KINASE MB; DILTIAZEM; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN; GLYCERYL TRINITRATE; HEPARIN; HIRULOG; HOMOCYSTEINE; LIPOPROTEIN A; LISINOPRIL; LOW DENSITY LIPOPROTEIN; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL; METOPROLOL TARTRATE; MORPHINE; MYOGLOBIN; PRASUGREL; TROPONIN I; TROPONIN T; UNINDEXED DRUG; VERAPAMIL; WARFARIN;

AGE DISTRIBUTION; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ANEMIA; ARTERY EMBOLISM; ATHEROSCLEROTIC PLAQUE; BARE METAL STENT; BRADYCARDIA; BRAIN HEMORRHAGE; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COCAINE DEPENDENCE; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISSECTION; CORONARY ARTERY THROMBOSIS; CORONARY REPERFUSION; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DRUG ELUTING STENT; DRUG TOLERABILITY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; ERYTHROCYTE SEDIMENTATION RATE; EXERCISE; FIBRINOLYTIC THERAPY; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONTRACTILITY; HEART MUSCLE NECROSIS; HEART MUSCLE PERFUSION; HEART MUSCLE REPERFUSION; HUMAN; HYPOTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEUKOCYTOSIS; LIFESTYLE MODIFICATION; MOLECULAR WEIGHT; MORBIDITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PARTIAL THROMBOPLASTIN TIME; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL EXAMINATION; PREDICTIVE VALUE; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK; SECONDARY PREVENTION; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SIDE EFFECT; SMOKING; SMOKING CESSATION; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TWO DIMENSIONAL GEL ELECTROPHORESIS; UNSTABLE ANGINA PECTORIS;

ANGINA PECTORIS; ARRHYTHMIAS, CARDIAC; HOSPITAL MORTALITY; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PLATELET AGGREGATION INHIBITORS; PRIMARY PREVENTION; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THROMBOLYTIC THERAPY;

EID: 84873573716     PISSN: 00115029     EISSN: 15578194     Source Type: Journal    
DOI: 10.1016/j.disamonth.2012.12.004     Document Type: Review

References (13)

1. Fuster V., Alexander R.W., O'Rourke R.A., et al. Hurst's The Heart 2009, McGraw-Hill Professional Publishing. 12th ed.
2. Alpert J.S., Thygesen K., Antman E., Bassand JP. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000, 36:959-969.
3. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. I Am Coll Cardiol 2007, 50:e1-e157.
4. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). J Am Coll Cardiol 2004, 44(3):E1-E211.
5. Antman E., Hand M., Armstrong P., et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. J Am Coll Cardiol 2008, 51:210-247.
6. Wright S., Anderson J., Adams C., et al. ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011, 123:2022-2060.
7. Antman E.M., Cohen M., Bernink P.J., et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. J Am Med Assoc 2000, 284:835-842.
8. Cannon C.P., Hand M.H., Bahr R., et al. Critical pathways for management of patients with acute coronary syndromes: an assessment by the National Heart Attack Alert Program. Am Heart J 2002, 143:777-789.
9. Krumholz H.M., Anderson J.L., Brooks N.H., et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the ACC/AHA task force on performance measures (ST-Elevation and Non-ST-Elevation Myocardial Infarction Performance Measures Writing Committee). J Am Coll Cardiol 2006, 47:236-265.
10. Mehta S.R., Cannon C.P., Fox K.A., et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. J Am Med Assoc 2005, 293:2908-2917.
11. Smith S.C., Allen J., Blair S.N., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 2006, 47:2130-2139.
12. Smith S.C., Feldman T.E., Hirshfeld Jr, et al. ACC/AHA/SCA1 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006, 113(7):e166-e286.
13. Weaver W.D., Cerqueira M., Hallstrom A.P., et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. J Am Med Assoc 1993, 270:1211-1216.